Menopausal therapy: benefits and risks 
Unanyan A.L.¹, Kuzenkova N.N.^2,3, Sidorova I.S.¹, Nikitina N.A.¹, Chushkov Yu.V.¹, Kudrina E.A.¹, Siordiya A.A.¹, Gadaeva I.V.¹, Baburin D.V.<sup>1

1</sup> The First Moscow State Medical University named after I.M. Sechenov 
² City Сlinic № 68 in Moscow
³ Peoples' Friendship University of Russia, Moscow

This publication is devoted to one of the most relevant areas of gynecological practice - menopausal therapy. The information is presented in the form of an analytical review of international studies of the benefits and risks of menopausal therapy. Given the rapid increase in the number of women in the middle and mature age, it is extremely important to identify the benefits and risks of menopausal therapy in order to optimize the quality of life and long-term well-being. Different variants of menopausal therapy can have both positive and negative sides, so in most cases an individualized approach is the most effective.
The conduct of menopausal hormone therapy can be associated with a number of undesirable risks, the development of adverse effectss, including vascular and oncological. The use of Cimicifuga racemosa as a medicine for menopausal therapy is characterized by the absence of any risks or side effects.
Personalized menopausal therapy, along with the observance of a healthy lifestyle (normalization of body weight, balanced nutrition, adequate physical activity, smoking and alcohol abuse cessation) is the basis for the health of women with menopausal disorders.
It is advisable to start the menopausal therapy  in the menopausal period or in the early postmenopause, when it is most effective.

Key words: menopausal therapy, climadinone, сimicifuga racemosa, herbal preparation, hormonal menopausal therapy, oncological risk, venous thromboembolism.
For citation: Unanyan A.L., Kuzenkova N.N., Sidorova I.S. et al. Menopausal therapy: benefits and risks  // RMJ. 2017. № 15. P.1128 –1134.